Skip to main content
. Author manuscript; available in PMC: 2020 Aug 30.
Published in final edited form as: Ultrasound Med Biol. 2019 Sep 14;45(12):3232–3245. doi: 10.1016/j.ultrasmedbio.2019.08.014

Figure 6.

Figure 6.

Graphs of percentage (%) by FACS (n=5 mice (10 tumors and 5 spleens)/PNP) of Calreticulin (Cal), PD1 and CTLA4 expression from either B16 (A) or 4T1 (B) tumors. B16 Cal (p=0.0027) and 4T1 PD1 (p= 0.042) with non-significant trends for decreased CTLA4 (p=0.051) and increased calreticulin (p=0.054).